| Takeda continues post-Shire selloff to the benefit of Korean biopharma Celltrion, says GlobalData South Korea-based bio/pharma company Celltrion has recently agreed to acquire a portfolio of 18 prescription pharmaceutical products and over-the-counter medicines across the Asia-Pacific (APAC) region for US$278.3m from Japan-based drug giant Takeda. This acquisition by Celltrion is part of Takeda’s massive divestment program to help release it from its crippling debt from its recent US$62bn Shire acquisition at the beginning of 2019. This acquisition will allow Celltrion to expand its portfolio into the small molecule pharmaceutical market within APAC, says GlobalData, a leading data and analytics company.The acquired product portfolio which includes Nesina, Edarbi, Actos and over-the-counter medicines that generated sales of US$140m in FY2018 within APAC territories, represents approximately 17% of Celltrion’s total revenues. The divestment of this product portfolio is part of Takeda’s plan to divest US$10bn of its non-core products and to balance its debt by the year 2022. This despite Takeda 2019 annual sales having increased by 56% from 2018 due to the Shire acquisition and a predicted continual compound annual growth of 6.2% over the next six years. Since its acquisition of Shire, Takeda has made a constant headway in its divesture strategy which has helped it to generate JPY968bn (US$9.3bn) from operations and divestitures enabled debt repayment of JPY701bn (US$6.5bn) in 2019 as compared to the divestiture goal of US$10bn to pare back the debt.Currently the Celltrion biologics portfolio is comprised of three biosimilars and a biologic, along with 37 generics that are marketed within the APAC geography. Celltrion also has a strong manufacturing base, with three facilities in South Korea capable of manufacturing both biological and solid dose products.According to GlobalData’s Pharma Intelligence Center, there are two innovator small-molecules in Celltrion’s pipeline; CTG-11 (Phase I) and CTG-20 (Phase I), both of which are in the cardiovascular portfolio.Bhavani Nelavelly, Pharma Analyst at GlobalData, says: “The acquisition of the Takeda portfolio will give Celltrion the opportunity to enter the lucrative small-molecules market in cardiovascular and metabolic disease areas.“This acquisition will allow Celltrion to establish itself as a key provider of both biologic and small-molecule products to the largest growing market in the world. In addition, the deal allows Celltrion to provide essential drugs for chronic diseases such as hypertension and diabetes for which many patients depend upon imported drugs.”Quentin Horgan, Drug Analyst at GlobalData, says: This acquisition; the first key acquisition of any foreign assets by Celltrion, is another indication of the strength of South Korean biologics and biopharma companies. That has been on the rise since last year when South Korea became only the seventh country to be placed on the EU’s whitelist of countries approved for GMP API imports. The industry as well is currently being pioneered by President Jae-in Moon who last year announced a plan to invest more than KRW2 trillion (US$1.7bn) in the next five years as part of a plan to make the country a leader in biotechnology and biopharmaceuticals.” ENDSFor more informationTo gain access to our latest press releases: GlobalData Media CentreAnalysts available for comment. Please contact the GlobalData Press Office:EMEA & Americas: +44 (0)207 832 4399 Asia-Pacific: +91 40 6616 6809Email: pr@globaldata.comTo gain access to our latest press releases and expert analysis on developments in your industry, please connect with us on:GlobalData | LinkedIn | Twitter Notes to EditorsComments provided by Bhavani Nelavelly, Pharma Analyst at GlobalDataand Quentin Horgan, Drug Analyst at GlobalDataThis press release was written using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis conducted by GlobalData’s team of industry expertsAbout GlobalData4,000 of the world’s largest companies, including over 70% of FTSE 100 and 60% of Fortune 100 companies, make timelier and better business decisions thanks to GlobalData’s unique data, expert analysis and innovative solutions, all in one platform. GlobalData’s mission is to help our clients decode the future to be more successful and innovative across a range of industries, including the healthcare, consumer, retail, financial, technology and professional services sectors. |
Author: trainitright
A nighttime whey protein snack increases morning blood sugar level in healthy people
Not peer reviewed Conference abstract People
Consuming protein at night increases blood sugar level in the morning for healthy people, according to new research presented this week at The Physiological Society’s virtual early career conference called Future Physiology 2020.
Having high blood sugar levels after eating is linked to health problems, such as diabetes, heart disease and obesity. Previous research has shown that a snack a few hours before a meal can help control blood sugar levels, which may partly explain why the first thing we eat each day (i.e. breakfast) tends to increase blood sugars more than other later meals.
This study investigated whether waking-up at night to consume some protein might keep blood sugars lower the next morning. Surprisingly, the blood sugar response to breakfast was higher when participants had consumed protein rather than plain water at 4 am.
These unexpected findings may be informative for people trying to improve their control of blood sugar levels.
One explanation for the result is that the body does not expect or need much food to be consumed during the night and so the protein itself was turned into sugar. This may result in the body having more carbohydrate already available upon waking such that the energy in the breakfast can less easily be used or stored, so it builds-up more in the blood.
The researchers at the University of Bath studied fifteen healthy young men and women (8 females and 7 males). The participants were woken up at 4 am to drink 300 ml of a water solution, either with or without 63 grams of whey protein.
They then went back to sleep and at 9 am were provided with a standard amount of porridge for breakfast, with blood samples collected for 2 hours afterwards to check the blood glucose response.
The participants then returned to the lab to do the same again a week or so later, but were provided with the other drink at night (4 am) so that we could compare the glucose response to the same breakfast in the same person and see the effects of the night-time protein.
Eleanor Smith, who presented the work, said:
“Future research will look at whether this applies to older and overweight people who tend to have more problems controlling their blood sugar levels. It would also be interesting to know to what extent our findings are due to eating at an unusual time or the type of protein consumed.”
Caption: This study investigated whether waking-up at night to consume some protein might keep blood sugars lower the next morning
Notes for Editors
- Link to conference abstract, page 197 https://static.physoc.org/app/uploads/2020/01/25092350/Future-Physiology-2020-programme-and-abstracts.pdf
- The Physiological Society brings together over 4,000 scientists from over 60 countries. The Society promotes physiology with the public and parliament alike. It supports physiologists by organising world-class conferences and offering grants for research and also publishes the latest developments in the field in its three leading scientific journals, The Journal of Physiology, Experimental Physiology and Physiological Reports. www.physoc.org
Experts Outline Key Steps for Hospitals to Welcome Back Family Caregivers During COVID-19
OTTAWA, ON, July 8, 2020 /CNW/ - Today, the Canadian Foundation for Healthcare Improvement released a new report that outlines key steps and resources for hospitals to welcome back family caregivers. The report, Re-Integration of Family Caregivers as Essential Partners in Care in a Time of COVID-19, was developed with experts from across the country including patient, family and caregiver partners.
In response to the COVID-19 pandemic, many hospitals in Canada closed the door on almost all visitors. This includes family caregivers who are designated by the patient to partner in their care. The important role of family caregivers is grounded in growing evidence that shows their presence benefits care, experience, safety and outcomes.
To help hospitals that are revisiting their policies move forward and reintegrate family caregivers as essential partners in care, CFHI convened a Rapid Response Expert Advisory Group composed of clinicians, healthcare system leaders, hospital CEOs, legal/bioethics experts, public health experts, and patient, family, and caregiver partners from across the country. They reviewed the evidence, considered the pandemic context and identified the following key steps:
- Ensure a foundation of patient- and family-partnered care
- Revisit policies on family presence with patient, family and caregiver partners at the table
- Distinguish between family caregivers who are essential partners in care and visitors
- Consider the needs of people who face specific risks without the presence of family caregivers as essential partners in care
- Take a comprehensive, balanced approach to assessing risks
- Establish a rapid appeal process
- Increase the evidence to guide decisions regarding family caregiver presence
Over the last five years, open family presence policies had become common in Canada's hospitals. In the winter of 2020, a CFHI study showed 73 percent of surveyed hospitals had accommodating visiting policies. By mid-March, the situation changed dramatically in response to COVID-19, and with some specific patient exceptions, none of the hospitals in a follow-up study had accommodating policies.
As leaders and organizations move to adjust blanket visitor restrictions, they can be guided by the report that shares evidence, resources and examples of patient- and family-partnered care that can be applied during a time of COVID-19. Creative and innovative approaches to support essential partners in care include clearly identifying family caregivers with name badges so that their role is clear, infection screening protocols (similar to healthcare staff) and infection control training (such as how to don and doff personal protective equipment).
Since 2010, CFHI has championed partnerships with patients and families to improve quality across the continuum of care. This includes the Better Together campaign and collaborative that supported hospitals across the country to review and improve their family presence policies.
CFHI will host a webinar to discuss the report and family presence policies with members of the advisory group on July 14 at 12.00 p.m. (EDT).
Quotes
"Family caregivers are essential partners in care – they are key allies for improving quality and safety. Many of us provide medical care, including complex procedures that require familiarity with infection control protocols. Family caregivers are knowledgeable, experienced and highly motivated to protect their loved ones," said Advisory Group member Maggie Keresteci, Caregiver with lived experience and Executive Director at Canadian Association for Health Services & Policy Research.
"The rapid shift to restrict access was done with the best intent, but extended restrictions also brings risks. We hope this report, and the resources within it, support hospitals and others who are revisiting policies and aiming to enable patient- and family-centred care during the pandemic," said Jennifer Zelmer, President and CEO of CFHI.
About the Canadian Foundation for Healthcare Improvement
The Canadian Foundation for Healthcare Improvement works shoulder-to-shoulder with partners to accelerate the identification, spread and scale of proven healthcare innovations. Together, we're delivering lasting improvement in patient experience, work life of healthcare providers, value-for-money and the health of everyone in Canada.
CFHI is a not-for-profit organization funded by Health Canada. The views expressed herein do not necessarily represent the views of Health Canada. Visit cfhi-fcass.ca for more information.
SOURCE Canadian Foundation for Healthcare Improvement
For further information:
or to arrange media interviews, please contact: Ashlee Biggs, Senior Communications Lead, Canadian Foundation for Healthcare Improvement, 613-728-2238 / Ashlee.Biggs@cfhi-fcass.ca
Why Buddha Never Had Alzheimer's: The Answer Can Be Found In Meditation, Yoga And Music
Roslyn Heights, NY, July 8, 2020—There are currently 5.8 million people in the U.S. today suffering from Alzheimer’s – a number that is expected to double by the middle of the century. Is it possible to stop or slow down this disease? Award-winning physician, scientist and author, Dr. Shuvendu Sen, says “Yes! It can be reversed, and even stopped altogether.” Dr. Sen shares expert advice and discusses the success being achieved through yoga, meditation and dancing/music therapy in Why Buddha Never Had Alzheimer's: A Holistic Treatment Approach through Meditation, Yoga and the Arts.
As the population of Americans with this disease continues to increase, so does the burden of caring for them. The cost of Alzheimer’s is staggering! This year alone, the cost for healthcare, long-term care and hospice services for those age 65 and older with dementia are estimated to be around $305 billion. Researchers in top institutions around the country indicate that the contributing factors to the disease (stress/hypertension) can be improved with holistic approaches, such as yoga, meditation, music and virtual reality therapy. We need an innovative breakthrough in order to make a difference; Why Buddha Never Had Alzheimer’s is the guide that can help make these necessary, far-reaching changes in medical care.
“How can meditation and yoga stop or even reverse Alzheimer's?” he asks. “They set the mind on an inward journey, built on a novel microenvironment where stress and its damaging inflict are permanently thwarted. This bridging of the old and new creates an imperative paradigm shift in our perspective toward managing this disease.”
Listed in the US Top Physician’s list, Dr. Sen is the author of the bestselling book, A Doctor's Diary, and is the recipient of the Nautilus Book Award, Men of Distinction Award from the New York State Senate, the Oscar Edwards Award from the American College of Physicians, and has been thrice nominated for the Pushcart Award for his columns and other works of fiction.
He has been an invited speaker to address United Nations officials, the New Jersey Senate, the Indian Consulate in New York, the World Book Fair, City University of New York, Harvard University and World Parliament of Religions. He has also been featured on many major television and radio stations.
To learn more about Dr. Sen and Why Buddha Never Had Alzheimer's, please visit: https://www.youtube.com/watch?v=FpaOnasKuDk.
Why Buddha Never Had Alzheimer's: A Holistic Treatment Approach through Meditation, Yoga and the Arts
HCI Publishers
Also translated into French by the prestigious Hachette Foundation
ISBN-10: 0757319947
ISBN-13: 978-0757319945
Available from Amazon and Barnes & Noble
###
Physician-Created App Unveils Remote Check-In Feature to Prevent Spread of COVID-19 in Medical Practices
TAMPA, FLA. - DocClocker®, a pioneering app that allows patients – for the first time – to receive real-time wait time reporting of their medical providers, has been aggressively preventing the spread of COVID-19 (coronavirus) nationwide by enabling patients to avoid long waits in medical waiting rooms – limiting exposure risks. Today, the company announced their latest achievement in supporting both providers and patients during the pandemic: DocClocker Remote Check-In.
In the wake of COVID-19, healthcare providers are being forced to rethink the traditional waiting room experience. DocClocker, a medical wait time reporting app that was founded and is run entirely by practicing physicians, is taking that step with the launch of DocClocker Remote Check-In. For the first time, patients can now remotely check-in to their doctor appointments from their car, in addition to receiving real-time wait time reporting; preventing the spread of the highly contagious virus by limiting the exposure of sick patients in waiting rooms.
“Recognizing that the waiting room during the COVID-19 pandemic is a potentially risky place to be, the new DocClocker Remote Check-In enables the healthcare system to function while keeping current best practice recommendations to maintain social distancing,” said Dr. Eric Carter, Co-CEO and Co-Founder of DocClocker.
Healthcare organizations across the United States are successfully using DocClocker to improve patient outcomes, prevent the spread of illness, increase new patient appointment bookings, improve practice online reputation and searchability, and much more. DocClocker can be installed and implemented to any healthcare waiting room in America in mere minutes.
In addition to remote check-ins and receiving real-time wait times, patients can easily locate and select in-network medical providers; selecting by reviewing the provider’s specific information and a display of average wait times. Patients can manage appointments through the app, receive appointment reminders, write reviews and report long waits. DocClocker is free to all patients and is significantly more affordable than basic appointment management tools that have dominated the market in recent years.
Remote Check-In Instructions: https://info.docclocker.com/remotecheckininstructions
PATIENTS
Download the App:
Apple: https://apps.apple.com/us/app/docclocker/id1321644191
Android: https://play.google.com/store/apps/details?id=com.docclocker.patient
PROVIDERS
Request a free demo: admin@docclocker.com
About DocClocker:
Developed by Fast Pathway Inc, DocClocker brings transparency to the doctor’s waiting room using modern technology to streamline communication between doctors, patients, and their families. For more information about DocClocker, please visit the app’s website at: https://docclocker.com/
Contact:
Molly Jacobson
Tel: 1-850-980-2793
Email: molly@jacobsonstrategy.com
Website: http://www.docclocker.com
Location Information:
Fast Pathway Inc
2202 North Westshore Blvd., Suite 200
Tampa, Florida 33607
About Fast Pathway, Inc:
Fast Pathway Inc is the developer and operator of the DocClocker® platform and maintains the cloud-based technology for subscribers and users.
If you would rather not receive future communications from Jacobson Strategy, let us know by clicking here.
Jacobson Strategy, 6304 Vista Verde Drive East, Gulfport, FL 33707 United States
Greg Palast’s How Trump Stole 2020: The Hunt for America’s Vanished Voters
Greg Palast
Greg Palast has a long history of investigative reporting. He’s written four New York Times bestsellers, including Armed Madhouse, Billionaires & Ballot Bandits, and The Best Democracy Money Can Buy. This incessant muckraker — always on the go, searching for and exposing corruption especially in electoral politics has written a new, soon to be released book, “How Trump Stole 2020“.
Feeling somewhat stifled and unable to travel in the age of Covid-19, Palast reached out to me this week, “Hey Sharon, I’m locked down and suffering because I should be in Wisconsin investigating another phony voter purge.” Greg rarely stays put. Because, as he puts it, “I watch these smug jerks and I’m ill … because I know something they won’t tell you. And here’s the facts, ma’am – in 2016, no fewer than 5,872,857 ballots were cast—and never counted”.
Palast has made it clear — he doesn’t pull any punches. The fix is in — billionaires run this country and Trump isn’t one of them. “Trump isn’t a billionaire: he just plays one on TV.” Greg says, “He’s only a glove puppet…I’ll give you the names of the billionaires whose fingers are in the glove. And what they’re grabbing.”
Palast’s newest release is bound to be a page turner but more important, he provides progressives with the information we need to turn this ship around.
Having spent decades honing his investigative chops spanning five continents, from the Arctic to the Amazon, from Caracas to California, writing front page stories for Rolling Stone, The Guardian, BBC NewsNight and others, Palast’s newest release is bound to be a page turner but more important, he provides progressives with the information we need to turn this ship around.
Greg makes it plain — “The 2020 election is not being stolen from Joe Biden — it’s been stolen from YOU.” But he also discusses how we can un-steal the election which is why we all need to pre-order “How Trump Stole 2020: The Hunt For America’s Vanished Voters”.
If we pre-order the book NOW the publicity will help to expose how the election is being stolen right now, and explain how we can steal it back: https://amazon.com/Trump-Stole-2020-Greg-Palast/dp/1644210568/?tag=wwwgregpala03-20
Following is a message Greg Palast wants spread far and wide:
Watch this video and share it with your friends. Help me get the word out on how to beat the ballot bandits: https://www.facebook.com/GregPalastInvestigates/videos/273835173697809/
Want to know who owns your ballot? Then get the book right now by ordering it on Amazon or Barnes & Noble or Bookshop. You’ll find all the links at: https://www.gregpalast.com/how-trump-stole-2020/
The Warrior’s Meditation Shares Best-Kept Secret In Stress Relief And Self-Improvement
Portland, OR, July 8, 2020 — The Warrior's Meditation by Richard L. Haight, the award-winning author of The Unbound Soul, makes transformative meditation accessible to the masses, with short, daily sessions that don’t require periods of isolation.
“The Warrior's Meditation is unlike any other meditation. This method is flexible in application, which allows it to blend with whatever your day has in store,” Haight says.
Perfect for people of all backgrounds and skill levels, The Warrior’s Meditation teaches an instinctive, non-religious form of Samurai meditation that is both practical and extremely effective.
Through daily meditation, practitioners can experience the following cognitive and physical benefits, among many others:
1. Improved immune function; decreased cellular inflammation and pain.
2. Increased positive emotions; less anxiety, depression and stress.
3. Increased emotional intelligence and compassion; reduced feelings of insecurity.
4. Increased gray matter in areas related to paying attention, positive emotions, emotional regulation and self-control.
5. Improved memory, creativity and abstract thinking.
Life is busy, and few people have time to spend hours a day in meditation. With The Warrior's Meditation, readers can experience profound clarity and awareness wherever they are and eventually embody meditation as a way of being.
Author Richard L. Haight is a master-level instructor of martial, meditation and healing arts. He began formal martial arts training at age 12 and moved to Japan at the age of 24 to advance his training with masters of the sword, staff and aiki-jujutsu.
During his 15 years in Japan, Haight was awarded masters licenses in four samurai arts as well as a traditional healing art called sotai-ho. He is one of the world's foremost experts in the traditional Japanese martial arts.
Through his books, his meditation and martial arts seminars, Haight is helping to ignite a worldwide movement for personal transformation that is free of all constraints and open to anyone of any level. He now lives and teaches in southern Oregon.
For more information, please visit richardlhaight.com.
The Warrior's Meditation: The Best-Kept Secret in Self-Improvement, Cognitive Enhancement, and Stress Relief, Taught by a Master of Four Samurai Arts
Publisher: Shinkaikan Body, Mind, Spirit LLC
ISBN-10: 0999210092
ISBN-13: 978-0999210093
Paperback available at all online bookstores.
Parler Praises Letter on Justice and Open Debate
Free speech platform commends principle behind letter calling for open dialogue, end to cancel culture
Washington, DC – Parler, the People-driven social platform, today applauded “A Letter on Justice and Open Debate.” The piece, published on-line and set to appear in Harpers Magazine, is signed by 150 prominent, ideologically diverse writers, scholars, artists, and journalists. While applauding recent activism calling for criminal justice reform and inclusion, the letter criticizes cancel culture and an “intolerant attitude that has set in on all sides.”
Quoting the letter:
“The free exchange of information and ideas, the lifeblood of a liberal society, is daily becoming more constricted. …[C]ensoriousness is…spreading more widely in our culture: an intolerance of opposing views, a vogue for public shaming and ostracism, and the tendency to dissolve complex policy issues in a blinding moral certainty. We uphold the value of robust and even caustic counter-speech from all quarters. But it is now all too common to hear calls for swift and severe retribution in response to perceived transgressions of speech and thought
…
“The restriction of debate… invariably hurts those who lack power and makes everyone less capable of democratic participation. The way to defeat bad ideas is by exposure, argument, and persuasion, not by trying to silence or wish them away.”
Letter signatories include world-renowned author J.K. Rowling, trumpet virtuoso Winton Marsalis, speechwriter for George W. Bush, David Frum, conservative columnist David Brooks, and progressive luminary Noam Chomsky.
“Parler is thrilled to see so many thought leaders coming together to support Free Speech and push back against Cancel Culture,” said CEO John Matze. “Parler is fighting to keep a free and open Public Square where the exchange of ideas can thrive. This letter’s call for open debate is precisely why we founded Parler and reflects our core values.”
Said Parler Strategic Investor Jeffrey Wernick, “The principle of open debate celebrated in this letter is among the core ideals that join us together as Americans, and as free, self-sovereign people. Parler applauds the brave authors of this letter and stands with them in defense of Free Speech. We hope they will all join us in the Public Square and continue to put our shared principles into action.”
Parler was founded in 2018 and has over 2.5 million users. The platform is committed to free speech, does not mine or sell user data, and does not censor content based on politics or ideology. Parler continues to stand with the People and against Technofascism.
Mitsubishi Tanabe Pharma Canada Announces that Nova Scotia has Added the Company's Treatment for Amyotrophic Lateral Sclerosis (ALS) to its Provincial Drug Plan Formulary
TORONTO, July 7, 2020 /CNW/ - Mitsubishi Tanabe Pharma Canada, Inc. (MTP-CA), a subsidiary of Mitsubishi Tanabe Pharma America, Inc. (MTPA), announced today that RADICAVA® (edaravone), an infusion treatment for amyotrophic lateral sclerosis (ALS), is now listed on the Nova Scotia Formulary (special authorization).
"We would like to thank the Government of Nova Scotia for providing eligible ALS patients living in the province access to this treatment," said Atsushi Fujimoto, President, MTP-CA. "ALS is a rapidly progressive, neurodegenerative and fatal disease. The listing of this therapy is excellent news for the ALS community in Nova Scotia."
In addition to the Nova Scotia Formulary (special authorization), RADICAVA is also listed on the:
- Régie de l'assurance maladie du Québec (RAMQ) formulary (special authorization);
- Ontario Drug Benefit Formulary (Exceptional Access Program);
- Alberta Drug Benefit List (special authorization);
- New Brunswick Drug Plan (NBDP) formulary (special authorization); and
- Saskatchewan Formulary (special authorization).
MTP-CA continues to have discussions with other provinces, territories and federal agencies regarding the listing of RADICAVA under additional publicly funded drug programs.
About RADICAVA® (edaravone)
RADICAVA (edaravone) is indicated to slow the loss of function in patients with amyotrophic lateral sclerosis (ALS), as measured by the ALS Functional Rating Scale - Revised (ALSFRSR).1 Edaravone was discovered and developed for ALS by Mitsubishi Tanabe Pharma Corporation (MTPC) through an iterative clinical development platform over a 13-year period. In 2015, edaravone was approved for use as a treatment for ALS in Japan and South Korea. RADICAVA was approved by the U.S. Food and Drug Administration in May of 2017. Marketing authorization was granted in Canada in October 2018 and Switzerland in January 2019.
About Mitsubishi Tanabe Pharma Canada, Inc.
Based in Toronto, Mitsubishi Tanabe Pharma Canada, Inc. (MTP-CA) is a wholly-owned subsidiary of Mitsubishi Tanabe Pharma America, Inc. (MTPA) with a goal to provide therapies for some of the most difficult-to-treat diseases, including ALS. For more information, please visit www.mt-pharma-ca.com.
About Mitsubishi Tanabe Pharma America, Inc.
Based in Jersey City, N.J., Mitsubishi Tanabe Pharma America, Inc. (MTPA) is a wholly-owned subsidiary of Mitsubishi Tanabe Pharma Corporation's (MTPC) 100 percent owned U.S. holding company, Mitsubishi Tanabe Pharma Holdings America, Inc. MTPA is dedicated to delivering innovative products that address the unmet medical needs of patients in North America. It was established by MTPC to commercialize approved pharmaceutical products in North America with plans to expand its product line through collaborations with partners. For more information, please visit www.mt-pharma-america.com.
| __________________________ | |
| 1 | RADICAVA® (edaravone) Canada Product Monograph. October 2019. https://www.mt-pharma-ca.com/our-product/ |
SOURCE Mitsubishi Tanabe Pharma Canada, Inc.
| Hi, In collaboration with an acclaimed cohort of chefs, restaurateurs, cookbook authors, scholars, and writers, YIVO Institute for Jewish Research presents a one-of-a-kind seven-week educational course, A Seat at the Table: A Journey Into Jewish Food. Now offered for free amid the COVID-19 global pandemic, A Seat at the Table has over 10,000 participants signed up to date. Lauded purveyors of Jewish fare and culture lead a riveting exploration into the Ashkenazi Jewish experience, and its modern culinary renaissance. Would you be interested in highlighting A Seat at the Table: A Journey Into Jewish Food? Never before has the world had such unprecedented access to over 100 hours of inspiring digital content at their finger tips, including in-depth interviews, roundtable discussions, cooking demonstrations, and the debut of 300 archival objects from YIVO for an inside look at an often mystified cuisine. A Seat at the Table: A Journey Into Jewish Food features cultural visionaries such as Joan Nathan (Jewish Cooking In America), Michael W. Twitty (The Cooking Gene), Alice Feiring (The Dirty Wine Guide), Mitchell Davis (James Beard Foundation), Niki Russ Federman and Josh Russ Tupper (Russ & Daughters), Jake Dell (Katz's Delicatessen), Darra Goldstein (Founder, Gastronomica: The Journal of Food and Culture), Liz Alpern and Jeffrey Yoskowitz (The Gefilteria), Lior Lev Sercarz (La Boîte), Adeena Sussman (Sababa), Ilan Stavans (Amherst College), Leah Koenig (The Jewish Cookbook), Michael Wex (Born to Kvetch), and more! For additional detailed information regarding YIVO Institute for Jewish Research and A Seat at the Table: A Journey Into Jewish Food, please see the press release below. Best, Jesse JP Cutler Media (e) jesse@jpcutlermedia.com (o) 510.658.3236 (w) https://yivo.org/food ******************************************** ***For Immediate Release*** Media Contact: Jesse P. Cutler JP Cutler Media 510.658.3236 jesse@jpcutlermedia.com YIVO Institute For Jewish Research Presents A Seat at the Table: A Journey Into Jewish Food Featuring Acclaimed Chefs, Cookbook Authors, Scholars, Restaurateurs, & Writers YIVO's Shine Online Educational Series Ventures Across Centuries of Jewish History & Culture, Discovering the Evolution of Ashkenazi Jewish Cuisine from Eastern Europe to the Streets of New York City To Unveil It's Modern Renaissance Throughout the 21st Century Amid the COVID-19 Global Pandemic, "A Seat at the Table" Now Offered for Free with Over 10,000 Participants Signed Up To Date New York City -- Monday, June 22, 2020 -- YIVO Institute for Jewish Research -- whose preeminent archives contain more than 23 million documents and artifacts about Eastern European Jewry -- collaborates with an esteemed cohort of chefs, restaurateurs, cookbook authors, scholars, and writers for a one-of-a-kind seven-week educational course, A Seat at the Table: A Journey Into Jewish Food. Never before has the world had such unprecedented access to over 100 hours of inspiring digital content at their finger tips, including in-depth interviews, roundtable discussions, cooking demonstrations, and the debut of 300 archival objects for an inside look at an often mystified cuisine. Lauded purveyors of Jewish fare and culture lead a riveting exploration into the Ashkenazi Jewish experience, and its modern culinary renaissance. A Seat at the Table: A Journey Into Jewish Food features cultural visionaries such as Joan Nathan (Jewish Cooking In America), Michael W. Twitty (The Cooking Gene), Alice Feiring (The Dirty Wine Guide), Mitchell Davis (James Beard Foundation), Niki Russ Federman and Josh Russ Tupper (Russ & Daughters), Jake Dell (Katz's Delicatessen), Darra Goldstein (Founder, Gastronomica: The Journal of Food and Culture), Liz Alpern and Jeffrey Yoskowitz (The Gefilteria), Lior Lev Sercarz (La Boîte), Adeena Sussman (Sababa), Ilan Stavans (Amherst College), Leah Koenig (The Jewish Cookbook), Michael Wex (Born to Kvetch), and more! The dynamism of Jewish cuisine is at once steeped in tradition, and embedded with great curiosities of a traveling migration of people evolving flavors and ingredients as they trekked across Eastern Europe, the Americas, and ultimately the cosmopolitan mecca of New York City. For thousands of years, Jewish dishes were confluent with the seasons and practices of sustainability. Recipes use flavors and textures from garden root vegetables, whole grains, fresh herbs, beef, lamb, and accompanied by seasonal fruit drinks, jellies, and a plethora of other nutritious foods. The Jewish food repertoire was at the heart of families and annual holidays. A Seat at the Table already has more than 10,000 online participants for an odyssey into the Ashkenazi Jewish kitchen through the lens of the brightest personalities within the field while supported by YIVO's extensive archives, including the largest collection of Yiddish cookbooks. Learn from experts the staples of Jewish food, sourcing of rich and flavorful ingredients, influence of South America on over 2,000 types of moles (served with latkes), lox slicing, the rise in national popularity of bagels, emergence of Jewish restaurateurs, evolution of Jewish delicatessens and cafes, cross-culturalization within immigrant groups on the Lower East Side (Jews, Chinese, Japanese), women's perseverance to provide nourishing meals, Vegetarianism, and much more. "A Seat at the Table shows the diversity of Jewish culture and the richness of Jewish history. Jews in Eastern Europe found ways to negotiate difficult times (political, social, economic, cultural) -- the result is a cuisine that shows their culinary creativity, resilience, and ability to find happiness, meaning, and nourishment (spiritual and physical) even in challenging times." -Jonathan Brent (Executive Director and CEO of YIVO). "A Seat at the Table takes a deep delve into YIVO's food-related archival collections, examining the full history of Ashkenazi Jewish foodways in collaboration with acclaimed scholars, chefs, and cookbook authors. The project lies at the center of YIVO's mission: rediscovering history, breaking through stereotypes, and reclaiming Jewish culture as a vibrant, living tradition -- one that can help shape our experiences." -Ben Kaplan (Director of Education, YIVO) Authentic Ashkenazi Jewish cuisine often reflects Jewish spiritual resistance as Jews faced extreme circumstances in their fight for survival and freedom. While food served to sustain and comfort people during the most difficult moments, A Seat at the Tableoffers foodies the opportunity to discover the cornerstones of the Ashkenazi Jewish kitchen. A process of assimilation and openness to new lands, people, and cultures uniquely identifies Jewish food as a traveling immigrant cuisine. The arrival of 3.5 million Jews to America from the 1880s -- 1920s provided access to an abundance of new foods and opportunities. What had become emblematic of the Jewish holidays throughout generations of hardship became more integrated into everyday life. A tragic history came full circle to centuries past for a cherished existence in America with new beginnings. YIVO's devotion to the study of Jewish history and folklore -- YIVO holds the largest collection of original Holocaust artifacts outside of Yad Vashem in Israel -- brings into focus its latest online educational program to center on Jewish food as the perfect aperitif for the greater understanding of Jewish culture. A Seat at the Table is among many exciting programs within the Shine Online Educational Series (LINK). Join YIVO and over 10,000 participants across the U.S. and 59 countries around the world for this powerful journey through Ashkenazi Jewish foodways. To sign up for A Seat at the Table, please visit: yivo.org/Food. Links to preview A Seat at the Table can be viewed below, and Artifacts & Recipes featured in A Seat at the Table can be downloaded at this LINK: Michael Twitty, "Culinary Justice" (Unit 2) https://www.youtube.com/watch?time_continue=15&v=q7iuYmp54g0 Josh Russ Tupper, "Lox Slicing with Russ & Daughters" (Unit 1) https://www.youtube.com/watch?v=_hONIQjLQW4 Jake Dell, "How to Build a Katz’s Sandwich" (Unit 5) https://www.youtube.com/watch?v=1PTkY03kJwQ Liz Alpern, Ilan Stavans, and Jeffrey Yoskowitz, "Latkes with Mole" (Unit 3) https://www.youtube.com/watch?time_continue=39&v=UwRxffwy9ko Barbara Kirshenblatt-Gimblett, "Bagels" (Unit 6) https://www.youtube.com/watch?v=kVzHy7Jstek Liz Alpern, Darra Goldstein, & Jeffrey Yoskowitz, "Ashkenazi Foodways" (Unit 1) https://www.youtube.com/watch?v=_qgEnkyOSrA Hasia Diner, "From Scarcity to Abundance" (Unit 3) https://www.youtube.com/watch?v=eQtNGq231qs Roundtable: "Ashkenazi Jewish Food and the Immigrant Experience" (Unit 3) https://www.youtube.com/watch?v=DtCwklsavcI About YIVO Institute for Jewish Research The YIVO Institute for Jewish Research was founded in Berlin, Warsaw, and in Vilnius (Vilna) in 1925. Its mission is to document, study, and preserve Ashkenazi Jewish civilization in all its aspects, from culture and history to language, literature, and political movements. YIVO's headquarters were relocated to New York City in 1940 in response to WWII. Today, YIVO is renowned for its role as a research institute, educational center, and cultural organization, with a library of over 400,000 volumes in addition to its unparalleled archive with over 23 million documents and artifacts. YIVO is dedicated to digitizing and preserving its collections for current and future generations worldwide. YIVO also keeps this heritage alive through its countless public and educational programs, which are conducted in person and digitally for a global community. For additional detailed information, please visit: yivo.org |
